Development of a novel meta-polygenic risk score for risk assessment and clinical manifestation prediction in systemic lupus erythematosus.

Although the difference in effect sizes between cSLE and aSLE did not reach statistical significance, these findings suggest the metaPRS’s potential to guide early intervention strategies tailored to disease-onset age.

also in 111,027 other papers